Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sihan Tan

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|January 8, 2023
[Advances in the Study of Tissue-resident Memory T Cells in Lung Cancer]Sihan Tan, Panwen Tian
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|February 18, 2025
[Predictive Value of Prognostic Nutritional Index in Prognosis and 
Spontaneous Pleurodesis of Patients with Advanced Non-small Cell Lung Cancer 
and Malignant Pleural Effusion]Sihan Tan, Weimin Li, Panwen Tian
BMC Pulmonary Medicine|February 16, 2024
Efficacy of bevacizumab through an indwelling pleural catheter in non-small cell lung cancer patients with symptomatic malignant pleural effusionHao Zeng, Yuanyuan Zhang, Sihan Tan, et al.
Clinical and Experimental Medicine|July 18, 2024
Current status and progress of PD-L1 detection: guiding immunotherapy for non-small cell lung cancerChang Qi, Yalun Li, Hao Zeng, et al.
Cardiovascular Toxicology|September 10, 2024
Steroid-Refractory Myocarditis Induced by Immune Checkpoint Inhibitor Responded to Infliximab: Report of Two Cases and Literature ReviewSihan Tan, Chang Qi, Hao Zeng, et al.
Chinese Medical Journal|November 30, 2023
Impact of non-canonical ALK fusion on the efficacy of targeted therapy in non-small cell lung cancerHao Zeng, Qi Wei, Yuan Tang, et al.
International Journal of Oncology|March 6, 2026
IL‑6: A key player in the EGFR‑TKI‑resistant tumor microenvironment and its therapeutic implications (Review)Qi Wei, Chengming Huang, Yuanyuan Zhang, et al.
Translational Lung Cancer Research|October 19, 2023
Superior clinical outcomes in patients with non-small cell lung cancer harboring multiple <i>ALK</i> fusions treated with tyrosine kinase inhibitorsQi Wei, Yuanyuan Zhang, Yongsheng Wang, et al.
Translational Lung Cancer Research|May 13, 2024
Efficacy of targeted therapy in patients with non-small cell lung cancer harboring very rare mutations in <i>EGFR</i> exon 18Yuanyuan Zhang, Hao Zeng, Chang Qi, et al.
Communications Engineering|January 7, 2026
Reasoning-agent-driven process simulation, optimization, carbon accounting and decarbonization of distillationSihan Tan, Xiaochi Zhou, Hai Zhou, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|January 8, 2023
[Advances in the Study of Tissue-resident Memory T Cells in Lung Cancer]Sihan Tan, Panwen Tian
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|February 18, 2025
[Predictive Value of Prognostic Nutritional Index in Prognosis and 
Spontaneous Pleurodesis of Patients with Advanced Non-small Cell Lung Cancer 
and Malignant Pleural Effusion]Sihan Tan, Weimin Li, Panwen Tian
BMC Pulmonary Medicine|February 16, 2024
Efficacy of bevacizumab through an indwelling pleural catheter in non-small cell lung cancer patients with symptomatic malignant pleural effusionHao Zeng, Yuanyuan Zhang, Sihan Tan, et al.
Clinical and Experimental Medicine|July 18, 2024
Current status and progress of PD-L1 detection: guiding immunotherapy for non-small cell lung cancerChang Qi, Yalun Li, Hao Zeng, et al.
Cardiovascular Toxicology|September 10, 2024
Steroid-Refractory Myocarditis Induced by Immune Checkpoint Inhibitor Responded to Infliximab: Report of Two Cases and Literature ReviewSihan Tan, Chang Qi, Hao Zeng, et al.
Chinese Medical Journal|November 30, 2023
Impact of non-canonical ALK fusion on the efficacy of targeted therapy in non-small cell lung cancerHao Zeng, Qi Wei, Yuan Tang, et al.
International Journal of Oncology|March 6, 2026
IL‑6: A key player in the EGFR‑TKI‑resistant tumor microenvironment and its therapeutic implications (Review)Qi Wei, Chengming Huang, Yuanyuan Zhang, et al.
Translational Lung Cancer Research|October 19, 2023
Superior clinical outcomes in patients with non-small cell lung cancer harboring multiple <i>ALK</i> fusions treated with tyrosine kinase inhibitorsQi Wei, Yuanyuan Zhang, Yongsheng Wang, et al.
Translational Lung Cancer Research|May 13, 2024
Efficacy of targeted therapy in patients with non-small cell lung cancer harboring very rare mutations in <i>EGFR</i> exon 18Yuanyuan Zhang, Hao Zeng, Chang Qi, et al.
Communications Engineering|January 7, 2026
Reasoning-agent-driven process simulation, optimization, carbon accounting and decarbonization of distillationSihan Tan, Xiaochi Zhou, Hai Zhou, et al.
Pageof 2